BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 283 filers reported holding BIONTECH SE in Q2 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19 | 0.0% | 178 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $19 | -13.6% | 178 | 0.0% | 0.01% | -12.5% |
| Q1 2023 | $22 | -18.5% | 178 | 0.0% | 0.01% | -27.3% |
| Q4 2022 | $27 | -99.9% | 178 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $24,000 | -36.8% | 178 | -31.0% | 0.01% | -31.2% |
| Q2 2022 | $38,000 | -13.6% | 258 | 0.0% | 0.02% | 0.0% |
| Q1 2022 | $44,000 | -42.1% | 258 | -12.8% | 0.02% | -38.5% |
| Q4 2021 | $76,000 | -12.6% | 296 | -6.9% | 0.03% | -23.5% |
| Q3 2021 | $87,000 | +22.5% | 318 | 0.0% | 0.03% | +17.2% |
| Q2 2021 | $71,000 | +102.9% | 318 | 0.0% | 0.03% | +61.1% |
| Q1 2021 | $35,000 | +34.6% | 318 | 0.0% | 0.02% | +28.6% |
| Q4 2020 | $26,000 | +62.5% | 318 | +33.6% | 0.01% | +40.0% |
| Q3 2020 | $16,000 | +433.3% | 238 | +526.3% | 0.01% | +400.0% |
| Q2 2020 | $3,000 | – | 38 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |